Copyright
©The Author(s) 2016.
World J Surg Proced. Jul 28, 2016; 6(2): 19-29
Published online Jul 28, 2016. doi: 10.5412/wjsp.v6.i2.19
Published online Jul 28, 2016. doi: 10.5412/wjsp.v6.i2.19
Characteristic | Surgery only varied size with cohort | Chemotherapy n = 64 matched patients | Radiotherapy n = 100 matched patients | Chemo and radio n = 57 matched patients |
30-d mortality (%) | 1.00 (reference) | 0.74 (0.16-3.43) | 1.24 (0.73-2.13) | 1.38 (0.79-2.43) |
Overall morbidity (%) | 1.00 (reference) | 1.10 (0.46-2.65) | 1.14 (0.80-1.62) | 1.38 (1.01-1.89)1 |
Serious morbidity (%) | 1.00 (reference) | 1.25 (0.50-3.13) | 1.00 (0.70-1.42) | 1.00 (0.72-1.38) |
Length of stay (d)2 | ||||
Predicted mean difference | 0.00 (reference) | -1.43 (-2.19 to -0.68)1 | 0.34 (0.08-0.60)1 | -0.04 (-0.28-0.21) |
Prolonged length of stay (%) | 1.00 (reference) | 0.56 (0.21-1.46) | 0.95 (0.68-1.31) | 0.78 (0.57-1.06) |
Operative time (min)2 | ||||
Predicted mean difference | 0.00 (reference) | 13.8 (10.7-17.0)1 | 19.9 (18.7-21.1)1 | 9.49 (8.41-10.6)1 |
Prolonged operative time (%) | 1.00 (reference) | 2.20 (1.00-4.87)1 | 1.56 (1.15-2.11)1 | 1.03 (0.79-1.34) |
- Citation: Mungo B, Zogg CK, Schlottmann F, Barbetta A, Hooker CM, Molena D. Surgical outcomes of pulmonary resection for lung cancer after neo-adjuvant treatment. World J Surg Proced 2016; 6(2): 19-29
- URL: https://www.wjgnet.com/2219-2832/full/v6/i2/19.htm
- DOI: https://dx.doi.org/10.5412/wjsp.v6.i2.19